Table 2.

Treatment-Related Adverse Events

Treatment-Related Adverse Event (N=76)*	Any Grade	Grade ≥ 3
Any	62 (81.6)	31 (40.8)
Fatigue	32 (42.1)	8 (10.5)
Diarrhea	16 (21.1)	2 (2.6)
Anemia	15 (19.7)	5 (6.6)
Decreased appetite	15 (19.7)	1 (1.3)
Platelet count decreased	12 (15.8)	1 (1.3)
Hypophosphatemia	11 (14.5)	7 (9.2)
Nausea	10 (13.2)	1 (1.3)
Blood alkaline phosphatase increased	8 (10.5)	1 (1.3)
Hypoalbuminemia	7 (9.2)	0 (0.0)
Hyponatremia	7 (9.2)	4 (5.3)
Vomiting	7 (9.2)	1 (1.3)
Weight decreased	7 (9.2)	0 (0.0)
Pneumonitis	6 (7.9)	3 (3.9)
Colitis	3 (3.9)	3 (3.9)
Edema	3 (3.9)	2 (2.6)

Treatment-related adverse events occurring in ≥ 9% of patients for all grade or ≥ 2 patient for grade ≥ 3